PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22223844-6	2012	In contrast, tumors that were less sensitive to anti-VEGF therapy showed an increase in (13)C flux from hyperpolarized [1-(13)C]pyruvate and an increase in uptake of a gadolinium contrast agent, whereas tumor ADC decreased.	Gadolinium	168-178	vascular endothelial growth factor A	Homo sapiens	53-57	
22915762-2	2012	It is well known that changes in the tumor microenvironment, such as hypoxia and glucose deprivation (GD), can induce VEGF production.	Gadolinium	102-104	vascular endothelial growth factor A	Homo sapiens	118-122	
22915762-6	2012	cDNA microarray results showed that GD-induced UPR activation promoted upregulation of a number of proangiogenic mediators (VEGF, FGF-2, IL-6, etc.)	Gadolinium	36-38	vascular endothelial growth factor A	Homo sapiens	124-128	
21521627-0	2011	Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.	Gadolinium	0-10	vascular endothelial growth factor A	Homo sapiens	61-65	
21521627-2	2011	Here, we designed a novel multifunctional polymeric nanoparticle contrast agent (Anti-VEGF PLA-PEG-PLL-Gd NP) simultaneously modified with Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) and anti-vascular endothelial growth factor (VEGF) antibody to deliver Gd-DTPA to the tumor area and achieve the early diagnosis of hepatocellular carcinoma (HCC).	Gadolinium	139-149	vascular endothelial growth factor A	Homo sapiens	86-90	
16763162-4	2006	During applied voltage ramps, VEGF activated a current that reversed at 0 mV, was sensitive to gadolinium, and required extracellular cations.	Gadolinium	95-105	vascular endothelial growth factor A	Homo sapiens	30-34	
15728605-1	2005	OBJECTIVE: The purpose of our study was to assess the correlation between the quantitative and qualitative imaging findings on unenhanced and gadolinium-enhanced MR images and the intensity of vascular endothelial growth factor (VEGF) expression in hepatocellular carcinomas and in the surrounding nontumorous liver.	Gadolinium	142-152	vascular endothelial growth factor A	Homo sapiens	193-227	
15728605-1	2005	OBJECTIVE: The purpose of our study was to assess the correlation between the quantitative and qualitative imaging findings on unenhanced and gadolinium-enhanced MR images and the intensity of vascular endothelial growth factor (VEGF) expression in hepatocellular carcinomas and in the surrounding nontumorous liver.	Gadolinium	142-152	vascular endothelial growth factor A	Homo sapiens	229-233	
15170848-0	2004	In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres.	Gadolinium	60-70	vascular endothelial growth factor A	Homo sapiens	20-54	
29970480-9	2018	Although both GBM108-vector and GBM108-VEGFA readily imaged on MRI following gadolinium contrast administration, GBM108-VEGFA tumors had a significantly enhanced drug and gadolinium accumulation, as determined by MALDI-MSI.	Gadolinium	171-181	vascular endothelial growth factor A	Homo sapiens	120-125